| Basics |
Johnson & Johnson
Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of products in the health care field within its Consumer, Pharmaceutical and Medical Devices segments.
|
| IPO Date: |
January 2, 1990 |
| Sector: |
Healthcare |
| Industry: |
Pharma |
| Market Cap: |
$486.51B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.69 | 0.64%
|
| Avg Daily Range (30 D): |
$1.30 | 0.67%
|
| Avg Daily Range (90 D): |
$1.18 | 0.64%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
7.96M |
| Avg Daily Volume (30 D): |
6.24M |
| Avg Daily Volume (90 D): |
6.12M |
| Trade Size |
| Avg Trade Size (Sh.): |
139 |
| Avg Trade Size (Sh.) (30 D): |
38 |
| Avg Trade Size (Sh.) (90 D): |
46 |
| Institutional Trades |
| Total Inst.Trades: |
159,316 |
| Avg Inst. Trade: |
$8.27M |
| Avg Inst. Trade (30 D): |
$27.76M |
| Avg Inst. Trade (90 D): |
$26.98M |
| Avg Inst. Trade Volume: |
.08M |
| Avg Inst. Trades (Per Day): |
28 |
| Market Closing Trades |
| Avg Closing Trade: |
$119.67M |
| Avg Closing Trade (30 D): |
$329.56M |
| Avg Closing Trade (90 D): |
$294.4M |
| Avg Closing Volume: |
929.05K |
|
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
$10.43
|
$2.14
|
$2.3
|
|
Diluted EPS
|
$10.36
|
$2.12
|
$2.29
|
|
Revenue
|
$ 92.15B
|
$ 23.99B
|
$ 23.74B
|
|
Gross Profit
|
$ 62.73B
|
$ 16.69B
|
$ 16.12B
|
|
Net Income / Loss
|
$ 25.12B
|
$ 5.15B
|
$ 5.54B
|
|
Operating Income / Loss
|
$ 31.5B
|
$ 7.49B
|
$ 6.49B
|
|
Cost of Revenue
|
$ 29.42B
|
$ 7.3B
|
$ 7.63B
|
|
Net Cash Flow
|
$ -1749M
|
$ -346M
|
$ -19897M
|
|
PE Ratio
|
19.49
|
|
|
|
|
|
